< Back to previous page
Researcher
Eva De Smedt
- Keywords:Medicine
- Disciplines:Natural sciences
Affiliations
- Hematology (Research group)
Member
From22 Mar 2021 → Today - Basic (bio-) Medical Sciences (Department)
Member
From15 Apr 2021 → 14 Apr 2023 - Basic (bio-) Medical Sciences (Department)
Member
From8 Apr 2019 → 31 Oct 2020 - Basic (bio-) Medical Sciences (Department)
Member
From1 Dec 2016 → 28 Feb 2017 - Faculty of Medicine and Pharmacy (Faculty)
Member
From6 Aug 2015 → 1 Jul 2021 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Immunology and Microbiology (Department)
Member
From1 Aug 2013 → 31 Dec 2013 - Faculty of Medicine and Pharmacy (Faculty)
Member
From23 Aug 2011 → 27 Jun 2013
Publications
1 - 4 of 4
- Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma(2021)
Authors: Laurie Herviou, Sara Ovejero, Fanny Izard, Ouissem Karmous-Gadacha, Claire Gourzones, Celine Bellanger, Eva De Smedt, Anqi Ma, Laure Vincent, Guillaume Cartron, et al.
- G9a/GLP-targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor mediated cell death(2021)
Authors: Eva De Smedt, Julie Devin, Catharina Muylaert, Nicolas Robert, Guilhem Requirand, Philip Vlummens, Laure Vincent, Guillaume Cartron, Ken Maes, Jerome Moreaux, et al.
Pages: 2325-2338 - Epigenetic reprogramming of malignant plasma cells: the therapeutic potential of RASSF proteins and G9a/GLP targeting in Multiple Myeloma.(2021)
Authors: Eva De Smedt, Karin Vanderkerken
- The Epigenome in Multiple Myeloma(2018)
Authors: Eva De Smedt, Hui, Lui, Ken Maes, Kim De Veirman, Eline Menu, Karin Vanderkerken, Elke De Bruyne